Who Generates More Revenue? Johnson & Johnson or Lantheus Holdings, Inc.

Revenue Battle: J&J vs. Lantheus - Who Leads?

__timestampJohnson & JohnsonLantheus Holdings, Inc.
Wednesday, January 1, 201474331000000301600000
Thursday, January 1, 201570074000000293461000
Friday, January 1, 201671890000000301853000
Sunday, January 1, 201776450000000331378000
Monday, January 1, 201881581000000343374000
Tuesday, January 1, 201982059000000347337000
Wednesday, January 1, 202082584000000339410000
Friday, January 1, 202178740000000425208000
Saturday, January 1, 202279990000000935061000
Sunday, January 1, 2023851590000001296429000
Monday, January 1, 202461350000000
Loading chart...

Data in motion

Revenue Showdown: Johnson & Johnson vs. Lantheus Holdings, Inc.

In the ever-evolving landscape of the healthcare industry, revenue generation is a key indicator of a company's market position and growth potential. Over the past decade, Johnson & Johnson has consistently outperformed Lantheus Holdings, Inc. in terms of revenue. From 2014 to 2023, Johnson & Johnson's revenue grew by approximately 15%, reaching a peak in 2023. In contrast, Lantheus Holdings, Inc. saw a remarkable increase of over 300% during the same period, albeit from a much smaller base. This growth trajectory highlights Lantheus's aggressive expansion strategy and its potential to capture a larger market share. Despite this impressive growth, Johnson & Johnson's revenue remains over 60 times greater than that of Lantheus Holdings, Inc. as of 2023. This comparison underscores the diverse scales at which these companies operate and their respective strategies in the competitive healthcare sector.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025